<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">Peritoneal carcinomatosis</z:e> is a common presentation in patients with <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> and the overall survival is poor </plain></SENT>
<SENT sid="1" pm="."><plain>In most patients, the disease remains limited to the peritoneal cavity </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, investigators have applied cytoreductive surgery and hyperthermic perioperative chemotherapy as the standard approach for selected patients with <z:e sem="disease" ids="C0346989" disease_type="Neoplastic Process" abbrv="">peritoneal metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Overall, very promising long-term survival has been shown in a subset of patients with a limited extent of <z:e sem="disease" ids="C0031142" disease_type="Disease or Syndrome" abbrv="">peritoneal disease</z:e> before treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Whether randomised, controlled trials are needed to definitively show the magnitude of benefit, if any, of this approach is an important question </plain></SENT>
<SENT sid="5" pm="."><plain>This Debate outlines the arguments on each side of this issue </plain></SENT>
</text></document>